High-risk acute lymphoblastic leukemia
Martínez Rubio, A.; Doñoro Mazario, M.; Sánchez Luna, M.; Muro Brussi, M.; Lamamie de Cleirac, P.; García-Monge Santidrián, S.
Anales Espanoles de Pediatria 29(Suppl 34): 66-68
1988
ISSN/ISBN: 0302-4342 PMID: 3214041 Document Number: 308009
Document emailed within 1 workday
Related Documents
Cáp, J.; Foltinová, A.; Kaiserová, E.; Babusíková, O.; Jamárik, M.; Jasenková, M. 1998: Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children? Neoplasma 45(3): 135-139Schmid, H.; Henze, G.; Schwerdtfeger, R.; Baumgarten, E.; Besserer, A.; Scheffler, A.; Serke, S.; Zingsem, J.; Siegert, W. 1993: Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia Bone Marrow Transplantation 12(6): 597-602
Hoelzer, D.; Thiel, E.; Löffler, H.; Büchner, T.; Ganser, A.; Heil, G.; Kurrle, E.; Heimpel, H.; Koch, P.; Lipp, T. 1987: Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1: 92-97
Iori, A.Paola.; Arcese, W.; Milano, F.; Calabrese, E.; Torelli, G.Fernando.; Barberi, W.; Mascolo, M.Grazia.; De Felice, L.; Screnci, M.; Lucarelli, B.; Malandruccolo, L.; Perrone, M.Paola.; Salvatori, S.; Laurenti, L.; Iannella, E.; Ricci, R.; Moleti, M.Luisa.; Foà, R. 2007: Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up Haematologica 92(8): 1051-1058
Soiffer, R.J.; Roy, D.C.; Gonin, R.; Murray, C.; Anderson, K.C.; Freedman, A.S.; Rabinowe, S.N.; Robertson, M.J.; Spector, N.; Pesek, K. 1993: Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse Bone Marrow Transplantation 12(3): 243-251
Balwierz, W.; Moryl-Bujakowska, A.; Skoczeń, S.; Pawińska, K.; Balcerska, A.; Płoszyńska, A.; Chybicka, A.; Dobaczewski, G.; Juszczak, K.; Wachowiak, J.; Derwich, K.; Kowalczyk, J.; Wiśniewska-Slusarz, H.; Matysiak, Mł.; Krauze, A.; Rokicka-Milewska, R.; Pawelec, K.; Sońta-Jakimczyk, D.; Łuszczyńska, A.; Tomaszewska, R.; Wysocki, M.; Styczyński, J.; Swiatkiewicz, V. 2003: Advances in the treatment of children with high risk acute lymphoblastic leukemia (ALL) treated with modified "NEW YORK" protocols between 1987 and 2002 Przeglad lekarski 60 Suppl. 5: 13-16
de Diego-Floreschapa, J.; López-Hernández, M.; Borbolla-Escoboza, J.R.; Trueba-Christy, E.; Carrillo-Rosales, T.; González-Avante, M. 1999: Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center Gaceta Medica de Mexico 135(3): 253-258
Zikos, P.; Van Lint, M.T.; Lamparelli, T.; Gualandi, F.; Occhini, D.; Bregante, S.; Berisso, G.; Mordini, N.; Incagliato, M.; Fugazza, G.; Sessarego, M.; Bacigalupo, A. 1998: Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse Haematologica 83(10): 896-903
Linker, C.A. 1997: Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL) Leukemia 11(Suppl): S24-S27
Chen, B.W.; Lin, D.T.; Lin, K.H.; Chuu, W.M.; Su, S.; Lin, K.S. 1989: An analysis of risk factor and survival in childhood acute lymphoblastic leukemia Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 30(5): 299-308
Meziane, F.; Borsali, T.; Taleb-Bendiab, R.; Bendouma, M.; Bouhass, R.; Aguercif, M. 1984: Acute lymphoblastic leukemia in children. Evaluation of risk factors and results of treatment in a pediatric milieu Pediatrie 39(2): 113-123
Komatsu, K. 1990: Effect of high-dose methotrexate on cerebral metabolic rate of glucose in rats and children with acute lymphoblastic leukemia No to Hattatsu 22(5): 477-482
Sasazaki, Y.; Asami, K.; Utsumi, J. 1992: Transient subacute encephalopathy induced by high-dose methotrexate treatment in children with acute lymphoblastic leukemia and malignant lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(11): 1851-1857
Porkhovatyĭ, S.I. 1982: Differential diagnosis of acute lymphoblastic leukemia and the lymphoblastic variant of lymphosarcoma in children Pediatriia 11: 19-23
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Lerede, T.; Bassan, R.; Rossi, A.; Di Bona, E.; Rossi, G.; Pogliani, E.M.; Motta, T.; Torri, V.; Buelli, M.; Comotti, B.; Viero, P.; Rambaldi, A.; Cortelazzo, S.; Rodeghiero, F.; Barbui, T. 1996: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma Haematologica 81(5): 442-449
Sanz, M.A.; Martínez, J.; Borrego, D.; Martín-Aragonés, G.; Lorenzo, I.; Sanz, G.; Sayas, M.J.; Jarque, I.; Pastor, E.; Rafecas, J. 1987: High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1): 18-20
Ludescher, C.; Eisterer, W.; Hilbe, W.; Gotwald, M.; Hofmann, J.; Zabernigg, A.; Cianfriglia, M.; Thaler, J. 1995: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia Leukemia 9(2): 350-356
Krance, R.A.; Forman, S.J.; Blume, K.G. 1987: Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia Cancer Treatment Reports 71(6): 645-647
Winchester, L.; Acevedo, S.; Guiven, A.; Pabon, M.; Montalvo, F. 2003: Evaluation of patient age as a risk assigment parameter in high risk acute lymphocytic leukemia Boletin de la Asociacion Medica de Puerto Rico 95(1): 26-28; 33-35